Major health insurers in Australia are in disagreement over the treatment of the diabetes and weight loss medication Ozempic, with benefits being slashed due to a worldwide shortage. Bernie Sanders faces challenges in pressuring pharmaceutical companies to lower prices. Hims is heavily investing in weight-loss drugs, introducing a Wegovy copycat. TikTok restricts promotion of weight-loss drugs like Ozempic to combat body-shaming. A new test predicts the effectiveness of weight-loss drugs. Novo Nordisk is unlikely to cut prices for GLP-1 drugs as demanded by Sanders.
$HIMS $NVO be like https://t.co/1Mdw8LEgPm
Ozempic, Wegovy, and Zepbound could prove useful for a range of conditions, from heart disease to addiction https://t.co/P6FKzta266
Hims is going all-in on weight-loss drugs with a Wegovy copycat https://t.co/kpr3iBJnCd via @business
absolutely wild that Ozempic is already having such an impact on consumer spending https://t.co/iiXLyykUvS
Replicas of weight loss drugs like Ozempic to be banned in Australian crackdown https://t.co/5OSztzMoXv
Hims & Hers got a shot in the arm this week that sent its share prices to near all-time highs. https://t.co/2hLefdeJPq
Hims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than Wegovy—with Mounjaro and Zepbound in its sights next. https://t.co/UwsOpw1INc
Imagine pumping your stock via blatant patent infringement $hims
NEW: While it may seem like everyone is taking Ozempic, not everyone can afford to. The high price of popular diabetes drugs prevents many people from getting them. @renurayasam reports. ⤵️ https://t.co/iOFiXPIUUB
$HIMS selling off premarket. Looks like a one day event
Drugs and procedures to help keep the weight off could fuel an even bigger bonanza than Ozempic and its many related compounds: https://t.co/8mWPpdAQKL https://t.co/VsJ0hYbdnM
New Wegovy clinical trial finds surprising benefits that go way beyond weight loss https://t.co/SUpKbcCXI8 https://t.co/ovWQ0MkE2s
🚨 STUDY: 'HUNGRY GUT' GENE BOOSTS WEGOVY EFFECTIVENESS Certain genes can predict strong responses to Wegovy, Novo Nordisk's weight-loss drug. Patients with the "hungry gut" gene lost an average of 14.4% of their body weight in 9 months, increasing to 19.5% after a year. Those… https://t.co/wj7UZ1y9xu
Compounding pharmacies (and also online peptide shops that don’t require a prescription at all) have been offering GLP-1s for years now. I don’t think HIMS is going to cut appreciably into NVO/LLY sales. HIMS will do a lot better though. Both things can be true.
$HIMS good luck with compounding obesity drugs in bulk. FDA warning to National Association of Board of pharmacies ⬇️⬇️ https://t.co/VMox0pPcfm
High price of Ozempic, other diabetes drugs deprive low-income people of effective treatment. https://t.co/y5HhijEYlg
Cheaper, generic version of weight-loss drugs like Ozempic. Legal in the US due to rules on compounding drugs that are in short supply. Not FDA approved. I wonder if consumers care about the latter? https://t.co/ctnmin93Tu
Weight Loss Commerce Space Picks Up Steam: Hims to Provide Compounded Peptides In a race to the bottom, who wins? https://t.co/AAN1oZgvob
The SF company behind generic Viagra pills is now selling an Ozempic copycat. 📝: https://t.co/3YqX0g4vCk ✍️ @stephencouncil https://t.co/cz2cOXyu9P
5 Investigates: Drugs advertised as alternatives to Ozempic, Wegovy posing health risks. Story producer: @gailwaterhouse Story on @WCVB: https://t.co/0VkfOFSwMC
As drugs such as Wegovy and Ozempic become harder to get, 5 Investigates found that some people across Greater Boston who are in search of weight loss help are turning to potentially risky alternatives. Story producer: @gailwaterhouse Story on @WCVB: https://t.co/0VkfOFSwMC
It may seem like everyone is taking Ozempic, but not everyone can afford to. The high price of popular diabetes drugs prevents many people from getting them. https://t.co/mTJs4Mjo36
And I covered $HIMS and $AMGN too https://t.co/0euox9eax6
Hims & Hers: finally, a reason to celebrate your dad bod. Get your GLP-1 injections online and skip the awkward doctor's visit. Your waistline (and wallet) will thank you. @jonnajarian @petenajarian $HIMS Rebel's Edge 🏴☠️ 1pm #itnotanoption #telehealth #weightloss #HIMS #dadbod https://t.co/OicfKpOTzH
Bernie Sanders is figuring out just how far bullying drugmakers can take him. https://t.co/7oLcCjy6f8
Shares of online health and wellness company @wearehims and @wearehers jumps 30% after it adds compounded GLP-1 injectable medications to its virtual weight loss offering: https://t.co/ZoG2BeAGC7
You like investing in drag queens and “LGBTQ Youth”? This is $HIMS https://t.co/rX2JKi0PY5
Beyond Wegovy, the Search Is On for Muscle-Saving Obesity Drugs https://t.co/FKZSJFHKqB https://t.co/i9BNMcYkwO
🚨🇺🇸 HIMS & HERS OFFERS BUDGET OZEMPIC FOR $50/WEEK Telehealth giant Hims will sell a "copycat" version of semaglutide, the active ingredient in Ozempic and Wegovy, for just $199 a month. This price includes unlimited doctor consultations, compared to Ozempic and Wegovy, which… https://t.co/YP5GJwhQPY https://t.co/wI6OMZVfyq
$Hims & Hers & Hamas https://t.co/lR5TVpp8VN
$HIMS was trading below 12 when the CEO came out of support of pro-Hamas l/anti-Israel student rallies. Since then several shady pump attempts have pushed the stock 50% higher. Weird https://t.co/Ug144HSusI
Viagra firm to begin offering 'budget' Ozempic prescriptions that cost $50 a week https://t.co/Mc6Zl2FoAP https://t.co/3WpbKa0V90
$HIMS yikes! https://t.co/X1Q0QrQ30D
Another Online Pharmacy Bypasses the FDA To Offer Cut-Rate Weight Loss Drugs https://t.co/l9dDBGdHYq
Another online pharmacy bypasses the FDA to offer cut-rate weight loss drugs https://t.co/MZSsp39i71
Stocks making the biggest moves midday: Hims & Hers Health, Norwegian Cruise Line, Target and more https://t.co/jBCpECJloe
Thanks for playing $hims https://t.co/LejVmLSelf
$HIMS more than double on equity from 9 Area 1st entry! https://t.co/VNCu9ZaGCS
Well, here's a new one. $HIMS is a SPAC that has not only met, but exceeded the promises made in their glossy SPAC deck. Revenue of $527 million with gross margins of 78% in 2022 easily topped their estimates of $233 million and 75%, respectively. In a world where SPACs tend to… https://t.co/nRfcPJ2mAR
Well, here's a new one. $HIMS is a SPAC that has not only beat, but exceeded the promises made in their glossy SPAC deck. Revenue of $527 million with gross margins of 78% in 2022 easily topped their estimates of $233 million and 75%, respectively. In a world where SPACs tend… https://t.co/aZTtgXQyZF
Popular diabetes and obesity drugs are often out of reach for the lowest-income patients. @renurayasam reports for KFF Health News & @CBSNews. https://t.co/vSTt3G9rFS
A $199 Ozempic copycat is here https://t.co/ZbyqtQPUKC
Breaking Taboos! Ozempic has been coined as the “celebrities floor to weight loss drug”… Very well reported fact is that I went from 352lbs on January of 2022 to 248lbs on November of 2022 while using Ozempic. Ozempic was created to help diabetics… And now it should be… https://t.co/LZ0WV6jNRV
That HIMS outrage lasted 2 weeks, stock has nearly doubled off the lows... https://t.co/4ElPeO4s0x
$HIMS been purposely taking their time on GLP-1s - intro shots at an 85% discount to Wegovy and stock massively squeezes shorts again
$HIMS up 3x since November, congrats to all investors who held the stock as it went from flaccid to very firm
Closed full position in $HIMS Nice quick profits on obesity news
$HIMS Just mention weight loss & GLP-1, stock will go to moon, FDA approved or not! Nice breakout 52week breakout though! https://t.co/1NyjF0BuMr
$HIMS Just mention weight loss & GLP-1, stock will go to moon, FDA approved or not! Nice breakout ATHs though! https://t.co/dhyUuReILM
$HIMS was just a trade for me but good luck with compounded drugs for obesity since they are not fda approved drugs so no way of telling if they are effective or not. Plus safety issues Just my two cents.
$HIMS 19 and 20 dollar holla! Oh My! https://t.co/MmNhdBRaS7 https://t.co/tgp1XJ4ota
Trimmed $HIMS 19.6+ from $15 area.
Sweetgreen $SG surges +6% as $HIMS (+24%) introduces GLP-1s
$HIMS 18 dollar holla! https://t.co/UWXBlHJp0C https://t.co/ykgXJCuURp
$HIMS and there is 17 holla! https://t.co/oE4a18YWDp https://t.co/TID5bzhndj
Sen. Bernie Sanders is demanding that Novo Nordisk cut prices for its blockbuster GLP-1 drugs. And that seems very, very unlikely. https://t.co/GdTfaEs1va
TikTok has released new rules that restrict users from promoting weight-loss drugs, like Ozempic, in order to block body-shaming imagery and related harmful messages. Here's how it's affecting the platform's weight-loss community: https://t.co/WM6yaQKstY
$HIMS 15 and 16 holla pre! https://t.co/oPpLqKWDYr
Sen. Bernie Sanders is testing the limits of the powers of a Senate chairman with little hope of advancing his drug-pricing agenda legislatively. https://t.co/2OEuMwgUtW
Hims is going all-in on weight-loss drugs with a Wegovy copycat https://t.co/AQIm8OJgbo
A new test predicts who will benefit most from weight-loss drugs https://t.co/u5ckgJYZqA
The high price of Ozempic and other diabetes drugs is depriving low-income people of effective treatment. https://t.co/rijaZWIH2J
Bernie Sanders may have reached the limits of his campaign to pressure pharmaceutical companies into lowering their prices. https://t.co/L7781fpGEQ
Australia's major health insurers are at odds over how to treat the diabetes and weight loss medication Ozempic, with one insurer slashing benefits amid a worldwide shortage. https://t.co/k4HnXQo9Ea